新規登録 | ログイン | FAQ      [?] 

Nature Reviews Drug Discovery

最近発刊の雑誌の目次より: Nature Reviews Drug Discovery © Nature Publishing Group
  • Molecular imaging in drug development
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 591-607.
    by Jürgen K Willmann, Nicholas van Bruggen, Ludger M Dinkelborg, Sanjiv S Gambhir
    posted by 1 person monkare
  • Creating and evaluating genetic tests predictive of drug response
    Nature Reviews Drug Discovery, Vol. 7, No. 7. (20 June 2008), pp. 568-574.
    by Scott T Weiss, Howard L Mcleod, David A Flockhart, Eileen M Dolan, Neal L Benowitz, Julie A Johnson, Mark J Ratain, Kathleen M Giacomini
    posted by 1 person psique
  • The exploration of macrocycles for drug discovery — an underexploited structural class
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 608-624.
    by Edward M Driggers, Stephen P Hale, Jinbo Lee, Nicholas K Terrett
  • What drives success for specialty pharmaceuticals?
    Nature Reviews Drug Discovery, Vol. 7, No. 7. (06 June 2008), pp. 563-567.
    by Mark Gudiksen, Edd Fleming, Laura Furstenthal, Philip Ma
  • Novel agents in cystic fibrosis
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 555-556.
    by Shane Storey, Graeme Wald
  • Purinergic signalling and disorders of the central nervous system
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 575-590.
    by Geoffrey Burnstock
    posted by 1 person psique
  • Metabolic disease: Blocking brain enzyme curbs appetite
    Nature Reviews Drug Discovery, Vol. 7, No. 7. (20 June 2008), pp. 560-561.
    by Sarah Crunkhorn
  • Dabigatran etexilate
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 557-558.
    by Bengt I Eriksson, Helen Smith, Uma Yasothan, Peter Kirkpatrick
  • Monoclonal antibodies: Expanding the mAb pool
    Nature Reviews Drug Discovery, Vol. 7, No. 7. (20 June 2008), pp. 561-561.
    by Bethan Hughes
  • Leukaemia: Targeting silent cells
    Nature Reviews Drug Discovery, Vol. 7, No. 7. (20 June 2008), pp. 562-562.
    by Monica H Flight
  • Vaccines: Mast cells key to new vaccine adjuvants
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 560-561.
    by Alexandra Flemming
  • Eye diseases: Convenient leakage reduction
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 559-559.
    by Charlotte Harrison
  • Patent Watch
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 552-553.
    by Charlotte Harrison
  • ASCO presentations highlight value of cancer biomarkers
    Nature Reviews Drug Discovery, Vol. 7, No. 7., pp. 547-548.
    by Alisa Opar
  • Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (23 May 2008), pp. 530-540.
    by Keith A Wafford, Bjarke Ebert
    posted by 1 person reyez
  • Drug development of MET inhibitors: targeting oncogene addiction and expedience
    Nature Reviews Drug Discovery, Vol. 7, No. 6., pp. 504-516.
    by Paolo M Comoglio, Silvia Giordano, Livio Trusolino
    posted by 2 people jyuh reyez
  • Follow-on biologics: data exclusivity and the balance between innovation and competition
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (12 May 2008), pp. 479-488.
    by Henry Grabowski
  • Schizophrenia therapy: beyond atypical antipsychotics
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (16 May 2008), pp. 471-472.
    by Eric M Snyder, Melanie R Murphy
  • Form to function: current and future roles for atherosclerosis imaging in drug development
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (16 May 2008), pp. 517-529.
    by Alistair C Lindsay, Robin P Choudhury
  • Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
    Nature Reviews Drug Discovery, Vol. 7, No. 6., pp. 489-503.
    by Masato Furuhashi, Gökhan S Hotamisligil
    posted by 1 person jyuh
  • Structural diversity of G protein-coupled receptors and significance for drug discovery
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (25 April 2008), pp. 542-542.
    by Malin C Lagerström, Helgi B Schiöth
  • Bendamustine
    Nature Reviews Drug Discovery, Vol. 7, No. 6., pp. 473-474.
    by Michael J Keating, Christian Bach, Uma Yasothan, Peter Kirkpatrick
  • Neurodegenerative disease: Inhibiting β-secretase where it matters
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (16 May 2008), pp. 475-475.
    by Monica H Flight
  • Neurodegenerative disease: A new pathway to autophagy
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (16 May 2008), pp. 476-477.
    by Charlotte Harrison
    posted by 1 person reyez
  • Molecularly targeted therapy: JAK2 inhibitor restores balance in polycythaemia vera
    Nature Reviews Drug Discovery, Vol. 7, No. 6., pp. 477-477.
    by Alexandra Flemming
  • Stem cells: Boosting myocardial repair
    Nature Reviews Drug Discovery, Vol. 7, No. 6., pp. 478-478.
    by Bethan Hughes
  • Cardiovascular disease: Novel antibody blocks thrombus formation
    Nature Reviews Drug Discovery, Vol. 7, No. 6. (16 May 2008), pp. 476-476.
    by Sarah Crunkhorn
  • Building the bridge from bench to bedside
    Nature Reviews Drug Discovery, Vol. 7, No. 6., pp. 463-464.
    by Jill U Adams
  • Globalization of sponsored clinical trials
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 458-458.
    by Johan PE Karlberg
  • Globalization of sponsored clinical trials: reply
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 458-458.
    by Fabio A Thiers, Anthony J Sinskey, Ernst R Berndt
  • Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 426-437.
    by Gerard Sanacora, Carlos A Zarate, John H Krystal, Husseini K Manji
  • The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 411-425.
    by Jeffrey A Winkles
  • Demographic factors in the Chinese health-care market
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 383-383.
    by Susan Ward
  • High-throughput kinase profiling as a platform for drug discovery
    Nat Rev Drug Discov, Vol. 7, No. 5. (May 2008), pp. 391-397.
    by David M Goldstein, Nathanael S Gray, Patrick P Zarrinkar
    posted by 4 people Yanno superpyrin oelemento renatomilani
  • Aliskiren: the first renin inhibitor for clinical treatment
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 399-410.
    by Chris Jensen, Peter Herold, Hans R Brunner
  • Targeting the endocannabinoid system: to enhance or reduce?
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 438-455.
    by Vincenzo Di Marzo
  • Ranbaxy loses in Caduet dispute
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 458-458.
    by Charlotte Harrison
  • The way forward in HCV treatment — finding the right path
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 458-458.
    by Michael P Manns, Graham R Foster, Jürgen K Rockstroh, Stefan Zeuzem, Fabien Zoulim, Michael Houghton
  • Autoimmune diseases: Targeting sugar coating
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 388-389.
    by Man T Tse
  • Antiparasitics: Fighting back against resistant worms
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 387-387.
    by Bethan Hughes
  • High-throughput screening: First fruits
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 388-389.
    by Monica H Flight
  • Cardiovascular disease: Spice might protect the heart
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 389-389.
    by Sarah Crunkhorn
  • Anticancer drugs: Scaffold to selectivity
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 390-390.
    by Charlotte Harrison
  • Rilonacept
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 385-386.
    by Hal M Hoffman, Uma Yasothan, Peter Kirkpatrick
  • Paul Ehrlich: founder of chemotherapy
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 373-373.
    by Stefan HE Kaufmann
  • Cardiovascular imaging in the light of ENHANCE
    Nature Reviews Drug Discovery, Vol. 7, No. 5., pp. 375-376.
    by Bethan Hughes
  • Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction
    Nature Reviews Drug Discovery, Vol. 7, No. 4., pp. 307-323.
    by Jarl ES Wikberg, Felikss Mutulis
  • Defining drug disposition determinants: a pharmacogenetic–pharmacokinetic strategy
    Nature Reviews Drug Discovery, Vol. 7, No. 4., pp. 293-305.
    by David A Katz, Bernard Murray, Anahita Bhathena, Leonardo Sahelijo
  • Cell-division inhibitors: new insights for future antibiotics
    Nature Reviews Drug Discovery, Vol. 7, No. 4., pp. 324-338.
    by Rowena L Lock, Elizabeth J Harry
  • Structural diversity of G protein-coupled receptors and significance for drug discovery
    Nature Reviews Drug Discovery, Vol. 7, No. 4., pp. 339-357.
    by Malin C Lagerström, Helgi B Schiöth
    posted by 2 people fernan superpyrin
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/nature-reviews-drug-discovery

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.